Capricor Therapeutics, Inc.CAPRNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+17.0%
5Y CAGR+1.9%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+17.0%/yr
vs +79.7%/yr prior
5Y CAGR
+1.9%/yr
Recent acceleration
Acceleration
-62.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 59.33% |
| 2024 | 16.07% |
| 2023 | 22.78% |
| 2022 | 37.04% |
| 2021 | 37.33% |
| 2020 | 54.10% |
| 2019 | -27.07% |
| 2018 | 3.55% |
| 2017 | -3.45% |
| 2016 | 12.83% |